As of 2026-08-19, the EV/EBITDA ratio of Cara Therapeutics Inc (CARA) is 0.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CARA's latest enterprise value is -13.59 mil USD. CARA's TTM EBITDA according to its financial statements is -61.10 mil USD. Dividing these 2 quantities gives us the above CARA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 12.1x | 8.0x |
| Forward P/E multiples | 11.5x - 15.2x | 14.0x |
| Fair Price | (145.46) - (153.75) | (138.77) |
| Upside | -2834.1% - -2990.0% | -2708.5% |
| Date | EV/EBITDA |